{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:36:01Z","timestamp":1785332161606,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jaut.2020.102442","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T09:53:33Z","timestamp":1585821213000},"page":"102442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy"],"prefix":"10.1016","volume":"109","author":[{"given":"Angela","family":"Ceribelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Ridgway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10224","key":"10.1016\/j.jaut.2020.102442_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jaut.2020.102442_bib2","article-title":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2","author":"Xu","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"20","key":"10.1016\/j.jaut.2020.102442_bib3","article-title":"Recent insights into 2019-nCoV: a brief but comprehensive review","volume":"S0163\u20134453","author":"Han","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.jaut.2020.102442_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u00a0314 cases from the Chinese center for disease control and prevention","author":"Wu","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jaut.2020.102442_bib5","doi-asserted-by":"crossref","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102442_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.immunol.25.022106.141706","article-title":"The immunobiology of SARS*","volume":"25","author":"Chen","year":"2007","journal-title":"Annu. Rev. Immunol."},{"issue":"24","key":"10.1016\/j.jaut.2020.102442_bib7","doi-asserted-by":"crossref","first-page":"e01504","DOI":"10.1128\/JVI.01504-18","article-title":"Lysosomal proteases are a determinant of coronavirus tropism","volume":"92","author":"Zheng","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2020.102442_bib8","doi-asserted-by":"crossref","DOI":"10.5582\/bst.2020.01047","article-title":"Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.jaut.2020.102442_bib9","first-page":"ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jaut.2020.102442_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"7","key":"10.1016\/j.jaut.2020.102442_bib11","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/JVI.01792-08","article-title":"Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells","volume":"83","author":"Yoshikawa","year":"2009","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.jaut.2020.102442_bib12","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome","volume":"23","author":"Le","year":"2018","journal-title":"Oncol."},{"key":"10.1016\/j.jaut.2020.102442_bib13","series-title":"Effective Treatment of Severe COVID-19 Patients with Tocilizumab","author":"Xu Xh","year":"2020"},{"key":"10.1016\/j.jaut.2020.102442_bib14","doi-asserted-by":"crossref","first-page":"102434","DOI":"10.1016\/j.jaut.2020.102434","article-title":"The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China","author":"Yang","year":"2020","journal-title":"J. Autoimmun."},{"issue":"10223","key":"10.1016\/j.jaut.2020.102442_bib15","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.jaut.2020.102442_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaut.2020.102442_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coviro.2017.11.002","article-title":"Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host","volume":"28","author":"Zheng","year":"2018","journal-title":"Curr. Opin. Virol."},{"issue":"16","key":"10.1016\/j.jaut.2020.102442_bib18","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1128\/JVI.00527-07","article-title":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome","volume":"81","author":"Cameron","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jaut.2020.102442_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-800100-4.00005-2","article-title":"The CD200-CD200R1 inhibitory signaling pathway: immune regulation and host-pathogen interactions","volume":"121","author":"Vaine","year":"2014","journal-title":"Adv. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2020.102442_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002710","article-title":"CD200 receptor controls sex-specific TLR7 responses to viral infection","volume":"8","author":"Karnam","year":"2012","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.jaut.2020.102442_bib21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0271678X15606148","article-title":"CD200 restrains macrophage attack on oligodendrocyte precursors via toll-like receptor 4 downregulation","volume":"36","author":"Hayakawa","year":"2016","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"7","key":"10.1016\/j.jaut.2020.102442_bib22","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.intimp.2011.01.013","article-title":"The role of myeloid receptors on murine plasmacytoid dendritic cells in induction of type I interferon","volume":"11","author":"Seeds","year":"2011","journal-title":"Int. Immunopharm."},{"issue":"3","key":"10.1016\/j.jaut.2020.102442_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/BOR.0000000000000598","article-title":"Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?","volume":"31","author":"Jani","year":"2019","journal-title":"Curr. Opin. Rheumatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112030055X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112030055X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:23:58Z","timestamp":1760257438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089684112030055X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":23,"alternative-id":["S089684112030055X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102442","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102442"}}